provid
protect
immun
neonat
anim
earli
life
associ
numer
challeng
regard
vaccin
safeti
much
simpler
approach
matern
vaccin
either
pregnanc
provid
neonat
passiv
transfer
immun
human
medic
societ
legal
risk
immun
pregnant
women
import
consider
undertak
approach
contrast
matern
vaccin
success
employ
anim
health
industri
decad
veterinari
vaccin
proven
safe
although
passiv
transfer
antibodi
extens
studi
immunolog
mechan
may
equal
import
provid
matern
deriv
immun
r
period
immedi
birth
critic
health
develop
anim
high
suscept
infecti
diseas
period
relat
varieti
factor
includ
immatur
immun
system
suscept
tolerogen
signal
barrio
et
al
particular
suboptim
interact
antigenpres
cell
tcell
inabl
cell
secret
cytokin
may
result
respons
qualit
adult
decreas
cytotox
cell
function
bcell
help
upham
et
al
altern
strategi
provid
earli
life
protect
infecti
diseas
matern
vaccin
human
medic
societ
legal
risk
immun
pregnant
women
pose
import
barrier
process
brent
contrast
activ
matern
vaccin
variou
anim
speci
practic
long
time
provid
good
level
safeti
protect
pathogen
placenta
eutherian
placent
mammal
share
common
structur
function
featur
also
strike
speci
gross
microscop
structur
placenta
two
characterist
form
basi
placent
type
shape
area
contact
fetal
matern
tissu
number
layer
tissu
matern
fetal
vascular
system
structur
placent
interfac
determin
natur
molecular
transport
across
placenta
primat
rodent
substanti
transfer
immunoglobulin
ig
g
matern
fetal
circul
prior
birth
contrast
transplacent
transfer
immunoglobulin
anim
like
cattl
sheep
hors
pig
speci
neonat
essenti
devoid
circul
antibodi
absorb
colostrum
antibodi
contain
colostrum
reach
neonat
vascular
circul
intestin
permeabl
immunoglobulin
hour
follow
birth
dog
addit
postnat
transfer
matern
igg
colostrum
passiv
immun
confer
fetu
last
third
pregnanc
et
al
whatev
placent
structur
transport
mechan
involv
success
matern
vaccin
programm
employ
variou
domest
anim
speci
exampl
matern
vaccin
use
cattl
dog
pig
discuss
overview
diarrhoea
common
newborn
calv
acut
diseas
character
progress
dehydr
death
sometim
littl
h
subacut
form
diarrhoea
may
persist
sever
day
result
malnutrit
emaci
sever
enteropathogen
associ
neonat
diarrhoea
preval
area
escherichia
coli
rotaviru
coronaviru
cryptosporidium
parvum
north
america
europ
variou
matern
vaccin
calf
diarrhoea
develop
inactiv
vaccin
shown
enhanc
antibodi
titr
colostrum
milk
vaccin
cow
case
two
primari
inject
given
sever
week
calv
follow
annual
booster
inject
subsequ
calv
safeti
pregnant
cow
new
born
calv
well
establish
studi
conduct
determin
amount
transfer
igg
requir
provid
protect
newborn
calf
infect
tyler
et
al
order
fulli
protect
matern
antibodi
must
cross
permeabl
intestin
barrier
h
neonat
life
moor
et
al
uptak
colostrum
depend
sever
factor
includ
genet
background
cow
aliment
sanitari
statu
calv
condit
control
method
ensur
good
passiv
transfer
feed
calv
concentr
antibodi
commerci
product
locatim
biokema
anstalt
furstentum
liechtenstein
confer
good
protect
neonat
enter
canin
enzoot
dog
popul
word
infect
associ
acut
usual
fatal
diseas
puppi
week
lifeth
pup
becom
infect
oronas
whelp
day
life
bitch
litterm
adult
dog
viru
caus
mild
infect
upper
respiratori
genit
tract
infect
pregnant
bitch
may
induc
stillbirth
abort
neonat
mortal
viru
also
strongli
suspect
caus
infertil
result
pathogen
role
may
caus
sever
reproduct
problem
high
econom
loss
breed
unit
chv
may
infect
puppi
earli
life
vaccin
bitch
repres
option
activ
prevent
diseas
inactiv
vaccin
avail
poulet
et
al
laboratori
studi
vaccin
shown
safe
pregnant
bitch
advers
reproduct
perform
case
vaccin
result
uniform
seroconvers
high
neutral
antibodi
titr
bitch
case
chv
diseas
record
puppi
produc
vaccin
bitch
moreov
result
trial
provid
strong
evid
vaccin
infertil
induc
viru
porcin
circoviru
type
accept
major
infecti
agent
involv
postwean
multisystem
syndrom
pwm
pwm
pig
week
life
clinic
sign
includ
progress
weight
loss
dyspnoea
tachypnoea
anaemia
diarrhoea
andjaundic
pwm
endem
mani
swineproduc
countri
caus
econom
impact
swine
industri
worldwid
pig
immun
system
fulli
understood
sever
studi
suggest
might
caus
immunosuppress
shibahara
et
al
segal
et
al
vincent
et
al
moreov
report
experiment
induc
immun
stimul
eg
vaccin
earli
life
induc
diseas
grasland
et
al
featur
matern
vaccin
regard
favour
option
provid
protect
pwm
piglet
born
sow
high
antibodi
titr
wellprotect
sever
challeng
contrast
piglet
age
born
sow
low
antibodi
titr
higher
viral
load
lymph
node
seriou
clinic
sign
lesion
develop
pwm
kill
vaccin
develop
recent
experi
conduct
pathogenfre
model
evalu
matern
protect
virul
challeng
piglet
born
vaccin
gilt
express
fewer
clinic
sign
lesion
lower
viral
load
serum
faec
lymph
node
compar
piglet
born
nonvaccin
gilt
field
studi
report
decreas
pwm
global
mortal
neonat
pig
suggest
passiv
immun
could
confer
longterm
protect
hypothes
mild
exposur
face
matern
deriv
immun
enabl
piglet
build
activ
immun
viru
mani
exampl
matern
vaccin
anim
exist
exampl
vaccin
sow
wide
use
protect
piglet
pig
neonat
colibacillosi
necrot
diarrhoea
erysipela
atroph
rhiniti
swine
aujeski
diseas
case
vaccin
proven
safe
protect
passiv
vaccin
alway
relat
presenc
antibodi
vaccin
mother
colostrum
howev
mechan
wherebi
matern
immun
confer
protect
may
exist
numer
constitu
colostrum
addit
antibodi
thought
potenti
contribut
passiv
immun
includ
innat
defenc
factor
lysozym
lactoferrin
peroxidas
complex
oligosaccharid
mucin
cytokin
chemokin
leucocyt
kelleh
lonnerd
establish
colostrumderiv
lymphocyt
migrat
gut
circul
lymphoid
organ
neonat
tuboli
bernath
transfer
lymphocyt
could
repres
sourc
cytokin
chemokin
exert
regulatori
neonat
antigenpres
cell
andtcel
sourc
arm
cell
abl
earli
infect
although
matern
deriv
antibodi
gener
consid
impair
neonat
respons
activ
vaccin
least
bcell
level
potenti
posit
gener
tcell
respons
requir
detail
investig
row
et
al
ration
design
appropri
matern
vaccin
programm
strategi
link
better
understand
mechan
matern
immun
confer
protect
newborn
veterinari
model
could
help
address
fundament
question
human
vaccin
